{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:12:33Z","timestamp":1793340753254,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES033345"],"award-info":[{"award-number":["ES033345"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["UL1TR002373"],"award-info":[{"award-number":["UL1TR002373"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.reprotox.2024.108827","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T16:51:17Z","timestamp":1735231877000},"page":"108827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Perfluoroalkyl substances (PFAS) exposure and preeclampsia risk: Impaired angiogenesis through suppression of VEGF signaling"],"prefix":"10.1016","volume":"132","author":[{"given":"Jay S.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara K.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Malecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Hetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2024.108827_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr. Environ. Assess. Manag."},{"key":"10.1016\/j.reprotox.2024.108827_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib3","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1039\/D0EM00355G","article-title":"The high persistence of PFAS is sufficient for their management as a chemical class","volume":"22","author":"Cousins","year":"2020","journal-title":"Environ. Sci. Process Impacts"},{"key":"10.1016\/j.reprotox.2024.108827_bib4","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1021\/acs.est.1c06896","article-title":"A New OECD definition for per- and polyfluoroalkyl substances","volume":"55","author":"Wang","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.scitotenv.2018.04.380","article-title":"A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs)","volume":"636","author":"Jian","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108827_bib6","unstructured":"Secretariat of the Stockholm Convention. All POPs listed in the Stockholm Convention. \u3008http:\/\/chm.pops.int\/TheConvention\/ThePOPs\/AllPOPs\/tabid\/2509\/Default.aspx\u3009 (2019)."},{"key":"10.1016\/j.reprotox.2024.108827_bib7","unstructured":"NIEHS. National Institute of Environmental Health Sciences. Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS). 2023, \u3008https:\/\/www.niehs.nih.gov\/health\/topics\/agents\/pfc\/index.cfm\u3009 (accessed July 30, 2024). In."},{"key":"10.1016\/j.reprotox.2024.108827_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105048","article-title":"Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey","volume":"131","author":"Calafat","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/acs.est.6b04590","article-title":"Novel chlorinated polyfluorinated ether sulfonates and legacy per-\/polyfluoroalkyl substances: placental transfer and relationship with serum albumin and glomerular filtration rate","volume":"51","author":"Pan","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.envint.2015.07.014","article-title":"Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns","volume":"84","author":"Cariou","year":"2015","journal-title":"Environ. Int"},{"key":"10.1016\/j.reprotox.2024.108827_bib11","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1021\/es3034654","article-title":"Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications","volume":"46","author":"Beesoon","year":"2012","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.reprotox.2024.108827_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106123","article-title":"Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019","volume":"145","author":"Gockener","year":"2020","journal-title":"Environ. Int"},{"key":"10.1016\/j.reprotox.2024.108827_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.envint.2018.01.025","article-title":"Influence of exposure to perfluoroalkyl substances (PFASs) on the Korean general population: 10-year trend and health effects","volume":"113","author":"Seo","year":"2018","journal-title":"Environ. Int"},{"key":"10.1016\/j.reprotox.2024.108827_bib15","article-title":"Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food","volume":"16","author":"Knutsen","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.reprotox.2024.108827_bib16","unstructured":"EPA. Health Effects Support Document for Perfluorooctane Sulfonate (PFOS). EPA 822-R-16-002. Washington, DC: U.S. EPA. In, vol. \u3008https:\/\/www.epa.gov\/sites\/production\/files\/2016-05\/documents\/pfos_hesd_final_508.pdf\u3009; 2016. \u3008https:\/\/www.epa.gov\/sites\/production\/files\/2016-05\/documents\/pfos_hesd_final_508.pdf\u3009."},{"key":"10.1016\/j.reprotox.2024.108827_bib17","unstructured":"US-EPA. Per- and Polyfluoroalkyl Substances (PFAS) Final PFAS National Primary Drinking Water Regulation. \u3008https:\/\/www.epa.gov\/sdwa\/and-polyfluoroalkyl-substances-pfas\u3009. 2024."},{"key":"10.1016\/j.reprotox.2024.108827_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12884-020-2765-x","article-title":"Associations between hydration state and pregnancy complications, maternal-infant outcomes: protocol of a prospective observational cohort study","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.reprotox.2024.108827_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.toxrep.2024.03.012","article-title":"Emerging contaminants in food matrices: An overview of the occurrence, pathways, impacts and detection techniques of per- and polyfluoroalkyl substances","volume":"12","author":"Eze","year":"2024","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.reprotox.2024.108827_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108756","article-title":"Linking exposure to per- and polyfluoroalkyl substances (PFAS) in house dust and biomonitoring data in eight impacted communities","volume":"188","author":"Minucci","year":"2024","journal-title":"Environ. Int"},{"key":"10.1016\/j.reprotox.2024.108827_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.109094","article-title":"Personal care product use and per- and polyfluoroalkyl substances in pregnant and lactating people in the Maternal-Infant Research on Environmental Chemicals study","volume":"193","author":"Hall","year":"2024","journal-title":"Environ. Int"},{"key":"10.1016\/j.reprotox.2024.108827_bib22","unstructured":"CDC. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization \u2014 United States, 2017\u20132019. \u3008https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7117a1.htm\u3009."},{"key":"10.1016\/j.reprotox.2024.108827_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semnephrol.2010.10.004","article-title":"Angiogenic factors and preeclampsia","volume":"31","author":"Maynard","year":"2011","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.reprotox.2024.108827_bib24","first-page":"147","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.reprotox.2024.108827_bib25","first-page":"1072","article-title":"Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries","volume":"107","author":"Dangudubiyyam","year":"2022","journal-title":"Dagger Biol. Reprod."},{"key":"10.1016\/j.reprotox.2024.108827_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108390","article-title":"Perfluorooctane sulfonic acid modulates expression of placental steroidogenesis-associated genes and hormone levels in pregnant rats","volume":"118","author":"Dangudubiyyam","year":"2023","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108827_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.reprotox.2020.09.008","article-title":"Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy increases blood pressure and impairs vascular relaxation mechanisms in the adult offspring","volume":"98","author":"Dangudubiyyam","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108827_bib28","doi-asserted-by":"crossref","DOI":"10.1289\/EHP9091","article-title":"Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk","volume":"129","author":"Bommarito","year":"2021","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108827_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1289\/ehp.1206372","article-title":"Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010","volume":"121","author":"Darrow","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108827_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117316","article-title":"Gestational hypertension, preeclampsia, and gestational diabetes mellitus after high exposure to perfluoroalkyl substances from drinking water in Ronneby, Sweden","volume":"239","author":"Ebel","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108827_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115006","article-title":"Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria","volume":"259","author":"Kaiser","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.reprotox.2024.108827_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106442","article-title":"Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort","volume":"151","author":"Birukov","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020043","article-title":"Per- and polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: a case-control study in Southern Sweden","volume":"8","author":"Rylander","year":"2020","journal-title":"Toxics"},{"key":"10.1016\/j.reprotox.2024.108827_bib34","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","article-title":"Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women","volume":"9","author":"Wikstrom","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2024.108827_bib35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwt432","article-title":"Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study","volume":"179","author":"Starling","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/354359","article-title":"Normal and pathological placental angiogenesis","volume":"2015","author":"Bardin","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006585","article-title":"Angiogenic factors in preeclampsia and related disorders","volume":"2","author":"Cerdeira","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.reprotox.2024.108827_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118543","article-title":"Perfluorooctane sulfonic acid (PFOS) inhibits vessel formation in a human 3D co-culture angiogenesis model (NCFs\/HUVECs)","volume":"293","author":"Forsthuber","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.reprotox.2024.108827_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060677","article-title":"PFOS inhibited normal functional development of placenta cells via PPARgamma signaling","volume":"9","author":"Li","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.reprotox.2024.108827_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.124491","article-title":"Developmental toxicity of the novel PFOS alternative OBS in developing zebrafish: An emphasis on cilia disruption","volume":"409","author":"Huang","year":"2021","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.reprotox.2024.108827_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2020.113566","article-title":"Perfluoroctanoic acid (PFOA) enhances NOTCH-signaling in an angiogenesis model of placental trophoblast cells","volume":"229","author":"Poteser","year":"2020","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.reprotox.2024.108827_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.119131","article-title":"Determinants of per- and polyfluoroalkyl substances (PFAS) exposure among Wisconsin residents","volume":"254","author":"Pomazal","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108827_bib43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41370-023-00593-3","article-title":"Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES)","volume":"33","author":"Schultz","year":"2023","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib44","unstructured":"Greendonner E. Maternal blood pressure program expands to help women facing health risks. \u3008https:\/\/www.med.wisc.edu\/news\/maternal-blood-pressure-program-expands\/\u3009. University of Wisconsin-Madiosn 2024. (last accessed December 11, 2024)."},{"key":"10.1016\/j.reprotox.2024.108827_bib45","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:1122-1131."},{"key":"10.1016\/j.reprotox.2024.108827_bib46","doi-asserted-by":"crossref","unstructured":"Committee Opinion No 700: Methods for Estimating the Due Date. Obstet Gynecol 2017; 129:e150-e154.","DOI":"10.1097\/AOG.0000000000002046"},{"key":"10.1016\/j.reprotox.2024.108827_bib50","unstructured":"Michigan Dept. of Community Health, Bureau of Laboratories. Document AC-54. Analysis of serum for PFAS by RP-HPLC-MRM-MS\/MS. 2018. Unpublished methods."},{"key":"10.1016\/j.reprotox.2024.108827_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajog.2012.08.010","article-title":"Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy","volume":"207","author":"McElrath","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108827_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105789","article-title":"Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study","volume":"141","author":"Borghese","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.envint.2013.10.004","article-title":"Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study","volume":"62","author":"Starling","year":"2014","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/aje\/kwp212","article-title":"Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome","volume":"170","author":"Stein","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12940-018-0445-3","article-title":"Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy","volume":"18","author":"Huang","year":"2019","journal-title":"Environ. Health"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108827_bib56","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3390\/w11102003","article-title":"Regulation of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS) in Drinking Water: A Comprehensive Review","volume":"11","author":"Pontius","year":"2019","journal-title":"Water"},{"key":"10.1016\/j.reprotox.2024.108827_bib57","unstructured":"NewHampshireDepartmentofHealthandHumanServicesDivisionofPublicHealthServices. Perfluorochemicals (PFCs) Blood Test Results. In. \u3008https:\/\/www.bedfordnh.org\/DocumentCenter\/View\/2473\/PFC-Results-Brochure_FINAL_100517\u3009; 2017."},{"key":"10.1016\/j.reprotox.2024.108827_bib58","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1021\/acs.est.9b07102","article-title":"Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina","volume":"54","author":"Bangma","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.envint.2019.01.010","article-title":"Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies","volume":"124","author":"Mamsen","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.scitotenv.2017.04.058","article-title":"Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma","volume":"596-597","author":"Mamsen","year":"2017","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108827_bib61","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1074\/jbc.M110.216812","article-title":"Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways","volume":"286","author":"Vicari","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2024.108827_bib62","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2144\/02333dd02","article-title":"Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay","volume":"33","author":"Zogakis","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.reprotox.2024.108827_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267826","article-title":"AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells","volume":"17","author":"Mishra","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2024.108827_bib64","unstructured":"R Core Team (2021). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. \u3008https:\/\/www.r-project.org\/\u3009."},{"key":"10.1016\/j.reprotox.2024.108827_bib65","unstructured":"Centers for Disease Control and Prevention CDC). 2019. Fourth National Report onHuman Exposure to Environmental Chemicals\u2014Updated Tables, January 2019,Volume One. \u3008https:\/\/www.cdc.gov\/exposurereport\/index.html\u3009."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108827_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13750-017-0114-y","article-title":"What is the effect of phasing out long-chain per- and polyfluoroalkyl substances on the concentrations of perfluoroalkyl acids and their precursors in the environment? A systematic review","volume":"7","author":"Land","year":"2018","journal-title":"Environ. Evid."},{"key":"10.1016\/j.reprotox.2024.108827_bib67","unstructured":"EPA. Risk Management for Per- and Polyfluoroalkyl Substances (PFAS) under TSCA. \u3008https:\/\/www.epa.gov\/assessing-and-managing-chemicals-under-tsca\/risk-management-and-polyfluoroalkyl-substances-pfas\u3009. In; United States Environmental Protection Agency. 2020."},{"key":"10.1016\/j.reprotox.2024.108827_bib68","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib69","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1021\/es8006244","article-title":"Use of newborn screening program blood spots for exposure assessment: declining levels of perluorinated compounds in New York State infants","volume":"42","author":"Spliethoff","year":"2008","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108827_bib70","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108827_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J. Afr."},{"key":"10.1016\/j.reprotox.2024.108827_bib72","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1289\/EHP10723","article-title":"Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program","volume":"131","author":"Padula","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108827_bib73","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/EDE.0b013e31824cb93b","article-title":"Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community","volume":"23","author":"Savitz","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.reprotox.2024.108827_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2024.142052","article-title":"Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort","volume":"357","author":"Thompson","year":"2024","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2024.108827_bib75","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"Pregnancy C. subtypes of preeclampsia: recognition and determining clinical usefulness","volume":"77","author":"Roberts","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.reprotox.2024.108827_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff","year":"2019","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.reprotox.2024.108827_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12884-018-1845-7","article-title":"Population-based trends and risk factors of early- and late-onset preeclampsia in Taiwan 2001-2014","volume":"18","author":"You","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.reprotox.2024.108827_bib78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108827_bib79","doi-asserted-by":"crossref","DOI":"10.1080\/1547691X.2024.2371868","article-title":"Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model","volume":"21","author":"Weatherly","year":"2024","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.reprotox.2024.108827_bib80","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive performance of PlGF (Placental Growth Factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis","volume":"74","author":"Agrawal","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.reprotox.2024.108827_bib81","first-page":"1","article-title":"Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis","volume":"17","author":"Veisani","year":"2019","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.reprotox.2024.108827_bib82","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","article-title":"Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis","volume":"182","author":"Allen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.reprotox.2024.108827_bib83","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.reprotox.2024.108827_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.reprotox.2020.10.013","article-title":"Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast","volume":"98","author":"Pham","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108827_bib85","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jnc.13422","article-title":"IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury","volume":"136","author":"Salmeron","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.reprotox.2024.108827_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2014.00114","article-title":"The role IL-1 in tumor-mediated angiogenesis","volume":"5","author":"Voronov","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib87","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/jmcc.1998.0895","article-title":"Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR\/flk-1 via activation of protein tyrosine kinases","volume":"31","author":"Maruyama","year":"1999","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib88","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10585-014-9639-4","article-title":"Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer","volume":"31","author":"Rupertus","year":"2014","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.reprotox.2024.108827_bib89","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/jpm-2014-0371","article-title":"Umbilical cord plasma interferon-induced protein 10 (IP-10) and interferon-induced T-cell alpha chemoattractant (ITAC) levels are lower in women with severe preeclampsia","volume":"44","author":"Chedraui","year":"2016","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.reprotox.2024.108827_bib90","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.reprotox.2024.108827_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.reprotox.2024.108827_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16106","article-title":"Pericyte-expressed Tie2 controls angiogenesis and vessel maturation","volume":"8","author":"Teichert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.reprotox.2024.108827_bib93","first-page":"773","article-title":"Tie2: a journey from normal angiogenesis to cancer and beyond","volume":"23","author":"Martin","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.reprotox.2024.108827_bib94","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.RES.81.4.567","article-title":"Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues","volume":"81","author":"Wong","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.reprotox.2024.108827_bib95","first-page":"671","article-title":"Involvement of endothelial PECAM-1\/CD31 in angiogenesis","volume":"151","author":"DeLisser","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.reprotox.2024.108827_bib96","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1074\/jbc.M112.417451","article-title":"Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells","volume":"288","author":"Mazor","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2024.108827_bib97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/NEN.0000000000000175","article-title":"TIMP-1 overexpression in lung carcinoma enhances tumor kinetics and angiogenesis in brain metastasis","volume":"74","author":"Rojiani","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.reprotox.2024.108827_bib98","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.4218","article-title":"Role of urokinase receptor in tumor progression and development","volume":"3","author":"Noh","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.reprotox.2024.108827_bib99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4161\/cam.22243","article-title":"VEGF-initiated angiogenesis and the uPA\/uPAR system","volume":"6","author":"Breuss","year":"2012","journal-title":"Cell Adhesion Migr."},{"key":"10.1016\/j.reprotox.2024.108827_bib100","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4081\/ejh.2014.2263","article-title":"Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells","volume":"58","author":"Ou","year":"2014","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.reprotox.2024.108827_bib101","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.placenta.2008.07.009","article-title":"In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts","volume":"29","author":"Kalkunte","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2024.108827_bib102","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood-2005-03-1000","article-title":"Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function","volume":"107","author":"Williams","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.reprotox.2024.108827_bib103","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.1103412","article-title":"Environmental impact on vascular development predicted by high-throughput screening","volume":"119","author":"Kleinstreuer","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108827_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105656","article-title":"Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study","volume":"138","author":"Huo","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108827_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13293-020-00299-3","article-title":"Fetal sex and maternal pregnancy outcomes: a systematic review and meta-analysis","volume":"11","author":"Broere-Brown","year":"2020","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.reprotox.2024.108827_bib106","first-page":"632","article-title":"Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis","volume":"46","author":"Global Pregnancy","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108827_bib107","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1471-0528.14163","article-title":"Fetal sex and maternal risk of pre-eclampsia\/eclampsia: a systematic review and meta-analysis","volume":"124","author":"Jaskolka","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2024.108827_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.156891","article-title":"Serum concentrations of selected perfluoroalkyl substances for US females compared to males as they age","volume":"842","author":"Jain","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108827_bib109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40572-022-00332-0","article-title":"An epidemiologic review of menstrual blood loss as an excretion route for per- and polyfluoroalkyl substances","volume":"9","author":"Upson","year":"2022","journal-title":"Curr. Environ. Health Rep."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:34:15Z","timestamp":1751524455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623824002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":106,"alternative-id":["S0890623824002946"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108827","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perfluoroalkyl substances (PFAS) exposure and preeclampsia risk: Impaired angiogenesis through suppression of VEGF signaling","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108827"}}